Overall rank by patents
#26,480
of 50,000 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 3 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
According to USPTO PatentsView, Hocor ranks #26,480 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 3 technology areas.
USPTO PatentsView assignee plate
Corpus R26480 · US Corporation #26,480 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Himalayan Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Hocor Cardiovascular · this assignee
32 score
3D Lighting Innovati… · lowest
7 score
What this shows Hocor's Innovation Score is 32.1/100 (top 60% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Hocor Cardiovascular Technologies Llc is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2017. By volume, Hocor sits between Himalayan Corporation and Hologram Industries.
Hocor Cardiovascular Technologies Llc shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
HIMALAYAN CORPORATION
10 patents
HITACHI APPLIANCES, INC
10 patents
HITACHI HIGH-TECH ANALYTICAL SCIENCE GMBH
10 patents
HITEC CO., LTD.
10 patents
HOK Product Design, LLC
10 patents
HOKKO CHEMICAL INDUSTRY CO., LTD.
10 patents
HOKURIKU ELECTRIC INDUSTRY CO., LTD.
10 patents
HOLOGRAM INDUSTRIES
10 patents
HOCOR CARDIOVASCULAR TECHNOLOGIES LLC
10 patents
What this shows Hocor holds 10 patents at rank #26,447, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,447 in granted patent volume.
Other assignees with the most granted patents in Hocor's primary technology class.
Hocor's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 Top 60% higher than 40% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 20.0% |
| 2017 | 1 | 10.0% |
| 2018 | 3 | 30.0% |
| 2020 | 1 | 10.0% |
| 2021 | 1 | 10.0% |
| 2022 | 1 | 10.0% |
| 2023 | 1 | 10.0% |
Top 3 of 3 technology areas
Overall rank by patents
#26,480
of 50,000 tracked assignees
32.1 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.